The impact of initial symptoms on survival time in advanced non-small cell lung cancer

被引：0
|
作者：
Miyawaki, T. [1 ]
Yagishita, S. [2 ]
Ko, R. [3 ]
Suzuki, Y. [1 ]
Matsumoto, N. [1 ]
Hara, M. [1 ]
Iwakami, N. [1 ]
Fujii, M. [1 ]
Iwakami, S-I. [1 ]
Takahashi, K. [3 ]
机构：
[1] Juntendo Univ, Shizuoka Hosp, Dept Resp Med, Shizuoka, Japan
[2] Juntendo Univ, Urayasu Hosp, Dept Resp Med, Urayasu, Japan
[3] Juntendo Univ Hosp, Dept Resp Med, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
479P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Chemotherapy for advanced non-small cell lung cancer
    Dubey, S
    Schiller, JH
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (01) : 101 - +
  • [42] Docetaxel in advanced non-small cell lung cancer
    Wakelee, H
    Ramalingam, S
    Belani, CP
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (01) : 13 - 24
  • [43] Pemetrexed in advanced non-small cell lung cancer
    Gridelli, Cesare
    Maione, Paolo
    Rossi, Antonio
    Bareschino, Maria Anna
    Schettino, Clorinda
    Sacco, Paola Claudia
    Zeppa, Rosario
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (02) : 311 - 317
  • [44] Cetuximab in advanced non-small cell lung cancer
    Govindan, R
    CLINICAL CANCER RESEARCH, 2004, 10 (12) : 4241S - 4244S
  • [45] Treatment of advanced non-small cell lung cancer
    De Petris, L
    Crinò, L
    Scagliotti, GV
    Gridelli, C
    Galetta, D
    Metro, G
    Novello, S
    Maione, P
    Colucci, G
    de Marinis, F
    ANNALS OF ONCOLOGY, 2006, 17 : 36 - 41
  • [46] Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Huang, Joy
    Reckamp, Karen L.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 400 - 408
  • [47] Chemotherapy for advanced non-small cell lung cancer
    Thatcher, N
    LUNG CANCER, 2001, 34 : S171 - S175
  • [48] Effect of time to treatment on survival in non-small cell lung cancer.
    Anggondowati, Trisari
    Ganti, Apar Kishor
    Watanabe-Galloway, Shinobu
    Haynatzki, Gleb
    Islam, K. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Impact of ramucirumab pharmacokinetics in combination with docetaxel on the efficacy and survival in patients with advanced non-small cell lung cancer
    Akagi, Kazumasa
    Yagishita, Shigehiro
    Ohuchi, Mayu
    Hayashi, Yoshiharu
    Takeyasu, Yuki
    Masuda, Ken
    Shinno, Yuki
    Okuma, Yusuke
    Yoshida, Tatsuya
    Goto, Yasushi
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Mukae, Hiroshi
    Ohe, Yuichiro
    Hamada, Akinobu
    LUNG CANCER, 2023, 178 : 247 - 253
  • [50] Non-small cell lung cancer - Advanced disease: Barriers to inclusion in clinical trials and its impact on survival
    dos Santos, Claudia Lares
    Fernandes, Ligia
    Sanches, Ines
    Cruz e Costa, Filipa
    Barata, Fernando
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345